Acute ischemic stroke is the leading cause of severe disability and the third leading cause of
death in the USA. Intravenous tissue plasminogen activator (IV tPA) remains the most widely …

Rapid, safe and effective arterial recanalisation to restore blood flow and improve functional
outcome remains the primary goal of hyperacute ischaemic stroke management. The benefit …

Mechanical treatment approaches for acute ischemic stroke treatment aim for fast and
efficient reperfusion with short procedure times and high recanalisation rates, thus extending …

Background and Objectives There is growing evidence for endovascular thrombectomy
(EVT) in patients with large ischemic core infarct and large vessel occlusion (LVO). The …

Background: This review aims to summarize the findings of the recently published
randomized controlled studies which provide overwhelming evidence in support of …

The recent success of endovascular stroke treatment has heralded a new era in the
management of acute ischemic stroke (AIS) with significantly improved outcome for patients …

Mechanical Thrombectomy for Acute Ischemic Stroke : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …

The treatment of stroke caused by intracranial vessel occlusion with intravenous
recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment …

Recommendations for Mechanical Thrombectomy in Patients with Acute Ischemic Stroke |
SpringerLink Skip to main content Advertisement SpringerLink Log in Menu Find a journal …

After being staggered by numerous negative trials in 2013, the interventional stroke
community saw four years of vindication for mechanical thrombectomy showing efficacy and …